Abstract
The oestrogen induced pS2 protein was measured in the cytosol of 446 breast cancer samples by an immunoradiometric assay. The relationships between pS2 and several clinical and biological parameters were evaluated. pS2 was not correlated to age, pT and nodal status, while it was higher in pre- than in peri- and post-menopausal women. A statistically significant positive association was found between pS2 and ER, PgR and cathepsin D. However, the frequency of pS2 negative values in ER+ (25.6%), PgR+ (21.7%) and cathepsin D-(19.0%) cases suggests that pS2 provides information independent of the above parameters in a fairly high percentage of patients. The prognostic role of pS2 was evaluated in 267 cases (follow up time 24-102 months). pS2+ showed longer RFS (P = 0.016) and OS (P = 0.004) than pS2-. pS2+ cases were significantly associated with a better prognosis in N+ but not in N- cases. Multivariate analysis showed that pS2 is an independent prognostic factor being the second most effective indicator for OS after nodal status and the third for RFS after nodal status and cathepsin D. From the present findings, we conclude that pS2 probably provides additional biological information to steroid receptor status and cathepsin D in patients with primary breast cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gion, M., Mione, R., Pappagallo, G. et al. PS2 in breast cancer – alternative or complementary tool to steroid receptor status? Evaluation of 446 cases. Br J Cancer 68, 374–379 (1993). https://doi.org/10.1038/bjc.1993.343
Issue Date:
DOI: https://doi.org/10.1038/bjc.1993.343
This article is cited by
-
Cytosolic levels of TFF1/pS2 in breast cancer: their relationship with clinical–pathological parameters and their prognostic significance
Breast Cancer Research and Treatment (2006)
-
Relationship among PS2 protein expression, estrogen and progesterone receptor status, and prognosis of breast cancer
Chinese Journal of Cancer Research (1999)
-
A second trefoil protein, ITF/hP1.B, is transcribed in human breast cancer
Breast Cancer Research and Treatment (1996)
-
Immunohistochemical determination of pS2 in invasive breast carcinomas: a study on 942 cases
Breast Cancer Research and Treatment (1995)